BriaCell Therapeutics (NASDAQ:BCTX) just reported results for the third quarter of 2024.
- BriaCell Therapeutics reported earnings per share of 11 cents. This was above the analyst estimate for EPS of -55 cents.
- The company did not report any revenue for the quarter.